In an obese mouse model, overexpression of FNDC5 enhances energy expenditure, lipolysis, and insulin sensitivity, and improves hyperlipidemia, hyperglycemia, and hyperinsulinemia (15). The gene discussed is INS; the disease is hyperlipidemia.